IngredientsIodine is a trace element that is naturally present in some foods, is added to some types of salt, and is available as a dietary supplement. Its chemical symbol is I, and it belongs to Group 17 (the halogens) of the periodic table, with atomic number 53. The term iodine comes from the French word iode, originally proposed by J.P. Gay-Lussac, derived from the Greek ἰοειδής due to its characteristic violet color in its gaseous state.
Historically, the only biological function attributed to iodine concerned its incorporation into thyroid hormones (THs), synthesized by the thyroid gland. THs, namely T₄ (3,5,3′,5′-tetraiodo-L-thyronine) and T₃ (3,5,3′-triiodo-L-thyronine), are characterized by the presence of four and three iodine atoms within the molecule, respectively, and play a prominent role in human body development and homeostasis.
In biological and physiological contexts, iodine is encountered predominantly as iodide (I⁻), the reduced ionic form. In supplemental and pharmaceutical preparations, it appears in several forms:
Iodine is present naturally at relatively high levels in seaweed, many saltwater fishes, and other seafood due to the ability to concentrate iodine from their seawater environment. Seaweed (such as kelp, nori, kombu, and wakame) is one of the best food sources of iodine. Other good sources include fish and other seafood as well as eggs. Dairy products also contain iodine.
Varying levels in foods are due to factors such as the amount of iodine in soil where crops are grown, extent of iodine supplementation to animals, use of iodophors as sanitizing agents, and iodine-containing ingredients in processed foods. Most fruits and vegetables contain little amounts of iodine, depending on the iodine content of the soil and fertilizer use. Similarly, cereals and bread are poor food sources of iodine unless fortified.
According to its label, iodized salt in the United States contains 45 mcg iodine/g salt (between 1/8 and 1/4 teaspoon); measured salt samples have an average of 47.5–50.7 mcg iodine/g salt. However, most salt intake in the United States comes from processed foods, and food manufacturers almost always use noniodized salt in these foods. Specialty salts, such as sea salt, kosher salt, Himalayan salt, and fleur de sel, are not usually iodized.
The ancient Chinese recognized goiter and the therapeutic effects of burnt sponge and seaweed in reducing its size or causing its disappearance. A Swiss physician by the name of J.F. Coindet had previously used burnt sponge and seaweed for the treatment of goiter (an enlargement of the thyroid gland). This treatment had been in use since 3600 B.C., when it appeared in Chinese medical writings, as well as writings by the Greek physician Hippocrates. These practitioners unknowingly were providing iodine to iodine-deficient patients, as seaweed and sponge are rich sources of the element.
In 1811, Bernard Courtois isolated iodine from seaweed, and then in 1820 Jean-François Coindet linked iodine intake to goiter size. Two years later, Gay-Lussac presented his study to the scientific community, announcing the discovery of a new element that he named "iodine," after the Greek word "ioeides" meaning violet colored. While he acknowledged Courtois as the original discoverer of the element, Gay-Lussac was the first to recognize iodine as a totally new substance.
Upon hearing of the work of Courtois and Gay-Lussac, Coindet suspected that iodine might be the active ingredient in seaweed that cured goiter. In 1819, he successfully tested a tincture of iodine on 150 patients, significantly reducing the size of their goiter within one week.
Physicians and surgeons quickly became enamored of iodine and its potential for treating a multitude of ills. The new substance was tested and tried for a huge variety of diseases and conditions. Tincture of iodine, or one of its forms, was applied to almost every type of case that otherwise resisted ordinary medicines. Between 1820 and 1840, there were dozens of essays in medical journals that attested to the amazing benefits of the use of iodine both internally and externally.
The modern use of iodine in the prevention of goiter dates from 1830, when it was proposed that goiter is an iodine deficiency disease due to lack of iodine in the water supply. But unfavorable symptoms of iodism were frequent owing to overenthusiastic use and overdose of iodine. Consequently, iodide prophylaxis was discredited and abandoned.
The presence of iodine in organic combination as a normal constituent of the thyroid was established in 1896, and the use of iodine in treatment and prevention of goiter was revived.
In 1831, French chemist and agronomist J.G. Boussingault proposed iodized sodium chloride (table salt) as a means of preventing goiter. Such a proposal was implemented first in Europe and then in the 1920s in the USA. In the United States, salt manufacturers have been adding iodine to table salt since the 1920s, although this practice is still voluntary. Globally, over 124 countries now have salt iodization programs.
Generation of thyroid hormones requires two main "ingredients": tyrosine (from thyroglobulin) and iodine (from the diet). The molecular steps in this process are well characterized:
Thyroid function is primarily regulated by thyroid-stimulating hormone (TSH), also known as thyrotropin. It is secreted by the pituitary gland to control thyroid hormone production and secretion, thereby protecting the body from hypothyroidism and hyperthyroidism. In conditions of low iodine and resulting reduced thyroid hormone production, compensation occurs through an increase in thyroid stimulating hormone (TSH) secretion from the pituitary, increased D2 activity, and resulting increase in T4 to T3 conversion.
Thyroid hormones regulate many important biochemical reactions, including protein synthesis and enzymatic activity, and are critical determinants of metabolic activity. They are also required for proper skeletal and central nervous system development in fetuses and infants.
Thyroid hormone receptors are found in cells throughout the body, and via gene transcription, thyroid hormones regulate a wide range of cellular and physiological functions essential for normal growth and development, neural differentiation, and metabolic regulation.
Iodine, through the action of different tissue-specific peroxidases, may serve different evolutionarily conserved physiological functions that, beyond TH biosynthesis, encompass antioxidant activity and defense against pathogens and cancer progression. Among the extrathyroidal organs capable of taking up iodine, the breast has gained increasing attention due to the strong correlation between iodine intake and breast health. It has been demonstrated that oral iodine supplementation therapy effectively relieved the symptoms of fibrocystic breast disease and objectively induced regression of fibrosis.
If selenium deficiency coexists with iodine deficiency, this reduces D2 activity and impairs the mechanism to compensate for low iodine. Iron also plays a role: the adequate availability and metabolism of three essential trace elements — iodine, selenium, and iron — provide the basic requirements for the function and action of the thyroid hormone system in humans.
Iodine sufficiency during pregnancy is extremely important for proper fetal development. During early pregnancy, when fetal thyroid gland development is incomplete, the fetus depends entirely on maternal T₄ and, therefore, on maternal iodine intake.
In pregnant women, severe iodine deficiency can permanently harm the fetus by causing stunted growth, intellectual disability, and delayed sexual development. Less severe iodine deficiency can cause lower-than-average IQ in infants and children and decrease adults' ability to work and think clearly.
Inadequate dietary intake of iodine in pregnancy is of special concern and can be associated with both maternal and fetal hypothyroidism, with retarded psychomotor development and irreversible mental retardation in the offspring.
The WHO and international bodies have made strong recommendations based on the body of evidence. The World Health Organization (WHO), United Nations Children's Fund, and the International Council for the Control of Iodine Deficiency Disorders recommend a slightly higher iodine intake for pregnant women of 250 mcg per day. To make adequate amounts of iodine available for proper fetal and infant development, several national and international groups recommend that pregnant and breastfeeding women and infants take iodine supplements. The American Thyroid Association recommends that women who are pregnant, planning to become pregnant, or breastfeeding take a daily supplement containing 150 mcg iodine as potassium iodide. The American Academy of Pediatrics has similar guidance.
Evidence strength: Strong and well-established for severe deficiency outcomes; evidence for the precise effects of mild-to-moderate deficiency correction in already iodine-sufficient populations is more mixed (see below under cognition).
Iodine deficiency remains one of the most serious global public health challenges, recognized as the leading cause of preventable brain damage worldwide. It is widely accepted as the primary aetiological factor underlying iodine deficiency disorders (IDD).
Mild reductions in maternal thyroid hormone levels in early pregnancy are associated with reduced IQ in offspring, and prenatal exposure to maternal hypothyroxinaemia increased the risk of expressive language delay and nonverbal cognitive delay in preschool-age children. Mild iodine deficiency during pregnancy may lead to hypothyroxinaemia in the mother and/or elevated thyroid-stimulating hormone levels in the foetus, and these conditions have been found to be related to mild and subclinical cognitive and psychomotor deficits in neonates, infants, and children.
Low maternal iodine status could be associated with an increased risk of suboptimal scores for verbal IQ at age 8 years and reading accuracy, comprehension, and reading scores at age 9 years. Correction of mild-to-moderate iodine deficiency improves cognitive performance in school-age children.
However, a 2023 systematic review published in PMC raised important nuances: its findings highlight a U-shaped association, whereby both insufficient and excessive iodine exposure during pregnancy and lactation may impair optimal brain development in the offspring. Furthermore, recent evidence demonstrated that 18-month-old children of mothers supplemented with 220–390 μg of KI per day had lower cognitive, language, and motor scores in some trials conducted in mildly deficient areas, suggesting that supplementation in populations already meeting baseline needs may not confer benefit and may carry risk.
There is an urgent need for well-designed, prospective, randomized controlled trials to evaluate the effects of supplementation on offspring cognition, particularly in populations with mild-to-moderate iodine status.
Evidence strength: Very strong for severe deficiency and its neurodevelopmental harms. Moderate for mild-to-moderate deficiency. Evidence for supplementation in iodine-sufficient pregnant women is mixed and inconclusive; the U-shaped risk relationship means excessive supplementation may itself be harmful.
Without enough iodine, thyroid hormones do not work properly and can lead to an underactive or overactive thyroid gland, causing the medical conditions of hypothyroidism and hyperthyroidism with various negative side effects in the body. The community-based strategy of iodine fortification in salt has eradicated iodine deficiency disorders (IDDs), such as endemic goiter and cretinism, in countries providing adequate measures of iodine prophylaxis over several decades in the 20th century. Iodized salt is the cornerstone of iodine prophylaxis in endemic areas, and continuous monitoring of community iodine intake and its related clinical outcomes is essential.
Evidence strength: Extremely well-established through decades of public health data from salt iodization programs worldwide.
Although not harmful, fibrocystic breast disease causes lumpy, painful breasts. It mainly affects women of reproductive age but can also occur during menopause. Very high doses of iodine supplements might reduce the pain and other symptoms of fibrocystic breast disease, but more study is necessary to confirm this.
One review of three clinical studies in a university-affiliated breast treatment setting, beginning in 1975, examined different forms of iodine: the objective was to determine the response of patients with fibrocystic breast disease to iodine replacement therapy using a review of three clinical studies: an uncontrolled study with sodium iodide and protein-bound iodide; a prospective, control, crossover study from iodide to molecular iodine; and a prospective, control, double-blind study with molecular iodine. Study 1 enrolled 233 volunteers with sodium iodide for 2 years and 588 received protein-bound iodide for 5 years. Study 2 switched 145 patients from protein-bound iodide to molecular iodine 0.08 mg/kg. Study 3 had 23 patients receive molecular iodine at 0.07 to 0.09 mg/kg body weight versus 33 receiving a placebo. The fibrocystic breast reacted differently to sodium iodide, protein-bound iodide, and molecular iodine. Molecular iodine was nonthyrotropic and was the most beneficial.
Although the results of these studies are promising, more research is needed to clarify iodine's role in fibrocystic breast disease. Moreover, the doses used in these studies (approximately 1,500–6,000 mcg per day) are several times higher than the iodine UL of 1,100 mcg for adults. Doses of this magnitude should only be used under the guidance of a physician.
Evidence strength: Preliminary; limited clinical trial data with small sample sizes, methodological limitations, and use of supratherapeutic doses. Not established as a standard recommendation.
Nuclear accidents can release radioactive iodine into the environment, increasing the risk of thyroid cancer in people who are exposed to the radioactive iodine, especially children. People with iodine deficiency who are exposed to radioactive iodine are especially at risk of developing thyroid cancer. The U.S. Food and Drug Administration has approved potassium iodide as a thyroid-blocking agent to reduce the risk of thyroid cancer in radiation emergencies.
Potassium iodide administered in pharmacologic doses (up to 130 mg for adults) within 48 hours before or eight hours after radiation exposure from a nuclear reactor accident can significantly reduce thyroid uptake of ¹³¹I and decrease the risk of radiation-induced thyroid cancer. The prompt and widespread use of potassium iodide prophylaxis in Poland after the 1986 Chernobyl nuclear reactor accident may explain the lack of a significant increase in childhood thyroid cancer compared to fallout areas where potassium iodide prophylaxis was not widely used.
Evidence strength: Well-established in the context of emergency use; supported by epidemiological data from Chernobyl and regulatory approval by the FDA.
The Recommended Dietary Allowance for iodine per day is 90 μg for children ages 1–8 years, 120 μg for children ages 9–13, 150 μg for males and most females ages 14 and older, 220 μg for pregnant women, and 290 μg for lactating women.
The Tolerable Upper Level per day for people over age 18 not receiving iodine for medical reasons is 1,100 μg.
Global dietary guidelines, including those from the WHO, recommend a daily iodine intake of 150 μg for adults, increasing to 250 μg during pregnancy to meet the physiological demands of increased maternal thyroid hormone production and the complete foetal dependence on the maternal iodine supply.
Median urinary iodine concentrations of 100–199 mcg/L in children and adults, 150–249 mcg/L in pregnant women and >100 mcg/L in lactating women indicate iodine intakes are adequate. Values lower than 100 mcg/L in children and nonpregnant adults indicate insufficient iodine intake, although iodine deficiency is not classified as severe until urinary iodine levels are lower than 20 mcg/L.
Nutrition Facts labels on foods do not usually list iodine unless the manufacturer has added iodine to the food. Therefore, Nutrition Facts labels cannot be relied upon to identify foods that naturally contain iodine, such as seaweed, fish, and other seafood. Iodine is also present in some dietary supplements, including products containing kelp and many multivitamin/mineral supplements.
Data from NHANES 2011–2014 indicated that less than 20% of U.S. pregnant and lactating women used a dietary supplement containing iodine.
Getting a very large dose of iodine (several grams, for example) can cause burning of the mouth, throat, and stomach; fever; stomach pain; nausea; vomiting; diarrhea; weak pulse; and coma. Mild symptoms of excess include gastrointestinal upset, nausea, vomiting, and diarrhea, which may progress to more severe manifestations such as delirium, confusion, lethargy, and shock. The condition is rarely fatal. Iodine toxicity most commonly results from overconsumption of dietary supplements.
Excessive iodine concentrations can lead to the Wolff-Chaikoff effect, which temporarily reduces the synthesis of T3 and T4, preventing excessive thyroid hormone production. Excess iodide transiently inhibits thyroid iodide organification. In individuals with a normal thyroid, the gland eventually escapes from this inhibitory effect and iodide organification resumes; however, in patients with underlying autoimmune thyroid disease, the suppressive action of high iodide may persist. The Wolff-Chaikoff effect lasts several days (around 10 days), after which it is followed by an "escape phenomenon," described by resumption of normal organification of iodine and normal thyroid peroxidase function.
Individual variabilities exist in the thyroid response to excess iodine intake due to the unmasking of underlying thyroid disease. Iodine excess can cause subclinical or overt thyroid dysfunction. The normal thyroid gland has defense mechanisms to block the stimulation of thyroid hormone production after a load of iodine, inciting the Wolff-Chaikoff effect that is typically temporary. Iodine excess can cause subclinical or overt thyroid dysfunction in patients with specific risk factors, including those with preexisting thyroid disease, older patients, fetuses, and neonates.
Iodine excess (IE), which may be caused by iodine-rich diets, supplements, iodinated contrast media, and salt iodization, has been implicated in a range of adverse outcomes on thyroid and systemic health. Examples include autoimmune thyroid diseases like Graves' disease and Hashimoto's thyroiditis, driven by immune cell polarization and gut microbiota alterations.
In some cases, failure of the Wolff-Chaikoff escape mechanism can lead to the Jod-Basedow phenomenon, characterized by excessive thyroid hormone production, particularly in individuals with thyroid nodules or impaired thyroid regulation. In subjects with lowered sensitivity, such as patients with endemic goiter and iodine deficiency, and in patients with nodular goiter containing autonomous nodules in iodine-replete nations, iodine excess may result in hyperthyroidism.
Children, infants, the elderly, and those with existing thyroid disease are particularly vulnerable to iodine toxicity and iodine-induced hypothyroidism and hyperthyroidism. Ingestion of greater than 1,100 mcg of iodine per day (the Tolerable Upper Limit for iodine) is not recommended and may cause thyroid dysfunction. During pregnancy and lactation, the recommendations for the upper limit vary and range from 500–1,100 mcg of iodine daily.
Given a Tolerable Upper Limit of 1,100 mcg iodine daily, ingestion of an iodine or kelp supplement containing in excess of 500 mcg iodine daily should not be done. A 2025 Norwegian clinical study demonstrated that ingestion of seaweed with high iodine content could potentially pose a risk of exceeding the tolerable upper intake level for iodine. Cessation of seaweed resulted in a significant decrease in TSH in the study.
Subjects under vegetarian dietary regimens, mainly the vegan ones, are at risk of developing both iodine deficiency and excess, due to lack of animal-derived foods on the one hand, and to the use of vegan alternatives (such as seaweed) and over-the-counter supplements on the other hand. A further risk for vegetarians would stem from the combined risk of having also iron and selenium deficiency, which would increase the detrimental effect of iodine deficiency on thyroid function.
Iodine supplements can interact with certain blood pressure medications and diuretics, including lisinopril, spironolactone, and amiloride, causing a dangerous buildup of potassium in the blood called hyperkalemia.
Propylthiouracil and carbimazole are antithyroid drugs used for the management of hyperthyroidism. They lead to a reduction in thyroid hormone synthesis through inhibition of thyroperoxidase, subsequently preventing the iodination of thyroglobulin. Iodine supplementation can antagonize the intended mechanism of these drugs and should not be co-administered without close supervision.
Amiodarone is known to have complex effects on thyroid function owing to its high iodine content. It has been implicated in causing both hyperthyroidism and hypothyroidism. Amiodarone may inhibit the peripheral de-iodination of T4 to T3, resulting in a decreased concentration of active hormone, which can cause more overt symptoms in patients with existing hypothyroidism; amiodarone is therefore contraindicated in patients with current or previous thyroid dysfunction.
Lithium may lead to clinical hypothyroidism due to a direct action on the thyroid gland, inhibiting the release of thyroid hormones. When used concurrently with large doses of iodine, the combined suppressive effects on thyroid hormone secretion may be additive.
People who get marginal amounts of iodine and who also eat foods containing goitrogens are at particular risk. Goitrogens are substances that interfere with the way the body uses iodine. The synthesis of the thyroid hormones is inhibited by certain chemical agents called goitrogens, which reduce the output of thyroid hormones, thereby causing, through negative feedback, an increased output of thyrotropin and hence an enlargement of the thyroid gland. Some goitrogens (e.g., thiocyanates) reduce or inhibit the uptake of iodide; others (e.g., thiourea, thiouracil) inhibit the peroxidase system and thus prevent the binding of iodine to thyroglobulin.
The use of iodinated contrast media in radiologic studies or invasive medical procedures is a common source of excessive iodine exposure and can lead to thyroid dysfunction. Despite the frequent use of contrast media in health care, the thyroid dysfunction associated with their use is poorly recognized.
Health conditions that Iodine may help support.
Iodine intake has a well-documented bidirectional relationship with autoimmune thyroid diseases (AITD), principally Hashimoto's thyroiditis and Graves' disease. Excessive iodine intake is an established environmental trigger for AITD in genetically susceptible individuals. Conversely, iodine deficiency also alters thyroid immunogenicity. AITD represents the most prevalent organ-specific autoimmune diseases, affecting 2–5% of the population.
Iodine deficiency impairs thyroid hormone synthesis, which slows metabolism and brain signalling, producing symptoms including mental sluggishness and 'brain fog'. Studies in communities with severe iodine deficiency document apathy and sluggishness in adults. Correcting deficiency restores thyroid hormone levels and can reverse these cognitive symptoms. Evidence is strongest for deficiency states; supplementation in already-sufficient individuals is not well-evidenced.
Iodine is actively concentrated in breast milk via the sodium-iodide symporter, making maternal iodine status the primary determinant of infant iodine intake during exclusive breastfeeding. The CDC recommends 290 µg/day for lactating women, higher than the non-pregnant adult RDA of 150 µg/day. Infant thyroid function and neurodevelopment depend directly on the iodine supplied through breast milk. Supplementation of deficient lactating women significantly raises breast milk iodine concentration.
Iodine-containing preparations (povidone-iodine, cadexomer iodine) are established antimicrobial agents used in burn wound management. Povidone-iodine has been used in burn care for decades; cadexomer iodine dressings have RCT evidence for burn wound infection control and healing support. Iodine kills a broad spectrum of burn wound pathogens.
Iodine is an essential trace element required for thyroid hormone synthesis, which regulates growth, neurological development, and metabolism in children. IOM-established RDAs for children are 90–120 µg/day. NIH ODS-funded label analysis found iodine in the 13 core nutrients at or above RDA in most children's MVMs.
Iodine deficiency is a direct cause of hypothyroidism, and fatigue is the cardinal symptom of hypothyroidism. Patients with low thyroid hormone levels, driven by iodine insufficiency, experience chronic, persistent tiredness unrelieved by rest. Population surveys confirm fatigue and weakness as the most common reported symptoms of iodine-deficiency-related low thyroid function. Correcting deficiency and restoring thyroid hormones reliably improves fatigue.
Iodine deficiency contributes to accelerated cognitive decline across the lifespan, including in older adults. A 2025 cross-sectional NHANES study found associations between urinary iodine concentration and composite cognitive scores in older Americans. A 2025 editorial in a peer-reviewed journal calls for lifespan-based public health strategies linking iodine sufficiency to protection of cognitive well-being into older age. The relationship is modulated by thyroid hormone status.
Iodine is an essential component of thyroid hormones T3 and T4, which regulate whole-body energy metabolism at the cellular level. Iodine deficiency leads to hypothyroidism, characterised by a markedly reduced metabolic rate and fatigue. Restoring adequate iodine intake in deficient individuals can normalise thyroid hormone levels and improve energy. The link is specifically to deficiency correction; evidence does not support energy enhancement in iodine-sufficient people.
Adequate thyroid hormone levels, dependent on sufficient iodine, are required for sustained attention and concentration. Iodine deficiency in children is associated with impaired reasoning abilities and overall cognitive function, including concentration. Supplementation in mildly deficient school-age children has been shown to improve these functions in randomised trials. Evidence pertains primarily to deficiency correction in children and, to a lesser extent, adults.
Thyroid hormones, synthesised using iodine, are required for normal hair follicle cycling and maintenance. Both iodine deficiency-induced hypothyroidism and iodine excess-induced hyperthyroidism can lead to telogen effluvium, resulting in diffuse hair thinning. Correcting the underlying thyroid dysfunction restores hair growth. The relationship is mediated through thyroid status rather than direct iodine action on the follicle.
Hair loss (telogen effluvium) is a well-recognised manifestation of both hypothyroidism and hyperthyroidism, both of which can be caused by abnormal iodine status. Iodine deficiency reduces thyroid hormone synthesis, shifting hair follicles into telogen phase. Excessive iodine can paradoxically trigger hyperthyroidism and a different mechanism of follicular damage. Thyroid hormone receptors are directly expressed in hair follicles.
Iodine is an essential trace element required for the synthesis of thyroid hormones (T3 and T4), which regulate metabolism, physical growth, and brain and cognitive development. The CDC recognizes that iodine deficiency is the most common cause of preventable mental retardation and can cause developmental delays. WHO and UNICEF have prioritized global iodine deficiency elimination as a public health imperative specifically to protect healthy growth and neurodevelopment in children.
Thyroid hormones, dependent on iodine, set the basal metabolic rate; iodine deficiency causing hypothyroidism slows metabolism and promotes weight gain. Cleveland Clinic and NIH-affiliated sources confirm weight gain as a direct symptom of iodine-deficiency hypothyroidism. Correcting deficiency can reverse this metabolic slowing. No evidence exists for weight loss benefit from iodine supplementation in iodine-sufficient individuals.
Iodine is the essential raw material for thyroid hormone (T3 and T4) synthesis, comprising 65% of T4 by weight. Deficiency leads to goiter, elevated TSH, and hypothyroidism. Both deficiency and excess carry risks; adequate intake is foundational to thyroid function and is recognized by WHO and all major endocrine bodies.
Iodine is essential for brain development, influencing neurogenesis, myelination, and synaptogenesis during critical windows. Deficiency during pregnancy and early childhood causes measurable and lasting impairments in learning capacity. In school-age children, mild deficiency is associated with lower IQ and reasoning scores, and iodine supplementation in deficient children improves cognitive learning outcomes. The relationship is strongest for developmental periods.
Iodine deficiency impairs thyroid hormone availability in the brain, disrupting memory consolidation and recall. Population data link low urinary iodine concentration to poorer performance on word learning and recall tests in older adults. Animal models and human studies of hypothyroidism both show memory deficits that are reversible with thyroid hormone repletion. The mechanism operates through thyroid hormones' regulation of hippocampal plasticity.
Iodine is an essential micronutrient whose primary and well-established biological role is as an obligate substrate for the synthesis of thyroid hormones T3 and T4. These hormones directly regulate basal metabolic rate, protein synthesis, and enzymatic activity across virtually all tissues. Iodine deficiency impairs thyroid hormone production, leading to hypothyroidism and its associated metabolic slowing, while adequate iodine intake is foundational to normal metabolic homeostasis.
Iodine requirements remain elevated postpartum in breastfeeding women (290 µg/day per CDC), as the thyroid gland must recover from the increased demands of pregnancy while also supplying iodine through breast milk. Postpartum thyroid dysfunction—including postpartum thyroiditis—is associated with iodine status and autoimmune thyroid activity. Inadequate iodine postpartum can prolong hypothyroid symptoms including fatigue and mood disturbance.
Iodine is essential for maternal thyroid hormone production, which drives fetal CNS myelination and brain development. Maternal iodine deficiency is associated with miscarriage, stillbirth, congenital hypothyroidism, and irreversible cognitive impairment in offspring. WHO, ACOG, NICE, and NIH ODS all recommend iodine supplementation during pregnancy. NIH ODS lists iodine among nutrients with critical prenatal roles that are underconsumed.
Iodine is the essential raw material for thyroid hormone synthesis; T3 and T4 each contain iodine atoms incorporated into tyrosine residues on thyroglobulin. Deficiency causes goiter, hypothyroidism, and—in severe cases—cretinism. Thyroid function follows a nonlinear relationship with iodine intake, where both deficiency and excess can impair function.
Povidone-iodine (PVP-I), an iodine-based antiseptic, has been studied extensively as a wound care agent. It possesses broad-spectrum antimicrobial activity, no reported bacterial resistance, and anti-inflammatory properties. Clinical evidence supports its use for surgical site preparation and intraoperative irrigation; evidence for direct wound-healing promotion is mixed but more recent reviews support appropriate use. It has been used clinically for wound antisepsis for over 150 years.
Body systems that Iodine may help support.
Go back